References
Niaudet P, Drachman R, Gagnadoux MF, Broyer M (1984) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Paediatr Scand 73:637–641
Mongeau JG, Robitaille PO, Roy F (1988) Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 2:398–410
British Association For Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555–1557
Symoens J, Veys E, Meillants M, Pinals R (1978) Adverse reactions to levamisole. Cancer Treat Rep 62:1721–1730
Ruuskanen O, Remes M, Makela AL, Isomaki H, Toivanen A (1976) Levamisole and agranulocytosis. Lancet II:958–959
Prieur AM, Buriot D, Lefur JM, Griscelli C (1978) Possible toxicity of levamisole in children with rheumatoid arthritis. J Pediatr 93: 304–305
Hsu WH (1980) Toxicity and drug interactions of levamisole. JAVMA 176:1166–1169
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Palcoux, J.B., Niaudet, P. & Goumy, P. Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8, 263–264 (1994). https://doi.org/10.1007/BF00865500
Issue Date:
DOI: https://doi.org/10.1007/BF00865500